Management Team

Walter Greenblatt, Chairman of the Board and CEO; Managing Director

Walter Greenblatt & Associates: Walter founded WG&A in 1998 focused solely on early stage life science companies. Since 2002, the firm has raised $122M in seed and Series A round capital for early stage life science companies and returned, to date, $622M to investors in those rounds. An experienced entrepreneur and “hands-on” operating executive, Walter has founded and grown to profitability a series of successful operating businesses. Earlier in his career he worked as a strategic consultant at Bain & Company in a variety of industries in including healthcare. Walter holds an BS from Yale University, an MA from Oxford University and an MBA from Harvard Business School.

Kathleen Deardorff, Chief Operating Officer

Kathleen has in depth cross functional proficiency, encompassing R&D, Commercial, Finance, Investor Relations. Manufacturing, Regulatory with expertise in Marketing in both large and small company settings in both diagnostic and therapeutic pharmaceutical portfolios; Previous roles: Chief Operating Officer, Photocure ASA, GE Healthcare Medical Diagnostics, Chief Marketing Officer, Bristol-Myers Squibb Co, Vice President Oncology Marketing, US; Senior Director, Worldwide Oncology Franchise Mgmt. Kathleen holds a Pharm D and a BS Pharmacy from Purdue University School of Pharmacy.

Dr. Stewart McCallum, Chief Medical Officer

Dr. Stewart McCallum is an accomplished board-certified surgeon with extensive experience in all phases of pharmaceutical development, from target validation through first, in human trials, Phase III trials, regulatory review, product launch, and post-marketing commitments.

As Chief Medical Officer for Baudax Bio, he oversaw cross-functional teams through all stages of drug development, leading to the approval and launch of Anjeso (IV Meloxicam), the first 24-hour IV analgesic for moderate to severe pain. Earlier, Stewart spent eight years in leadership positions at GlaxoSmithKline, including clinical development for NCEs across a range of conditions, Clinical Director for the Oncology Business Development Unit and Director of Clinical Pharmacology for the Cardiovascular and Urology Center of Excellence for Drug Development.

Before this, Stewart was an Assistant Professor of Urology at Stanford University Stewart was a Clinical Fellow in the Department of Urology at New York Hospital Cornell Medical Center He completed a Residency at the Department of Urology at the University of Toronto and a Comprehensive Surgical Internship at Mount Sinai Hospital in Toronto. He earned a Doctor of Medicine ( at the University of Toronto and a Bachelor of Science (BSc with honors) in Biochemistry at the University of Western Ontario.